By David Stout
Attorneys in New England reached a proposed $100 million settlement on Tuesday with the owners of the pharmaceutical operation that produced tainted drugs responsible for the 2012 nationwide meningitis outbreak that killed 64 people.
The $100 million deal will provide compensation to insurers and victims of the outbreak in accordance with a Chapter 11 plan filed by the owners of New England Compounding Pharmacy Inc., according to Bloomberg.
The outbreak, which infected more than 700 people, was largely blamed on a steroid administered by spinal injection that was produced by the company.
A judge must still approve the settlement along with a system that will distribute the funds to victims awaiting compensation.
More Must-Reads From TIME
- The 100 Most Influential People of 2024
- How Far Trump Would Go
- Scenes From Pro-Palestinian Encampments Across U.S. Universities
- Saving Seconds Is Better Than Hours
- Why Your Breakfast Should Start with a Vegetable
- 6 Compliments That Land Every Time
- Welcome to the Golden Age of Ryan Gosling
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
Contact us at letters@time.com